ENTITY
Pacific Edge

Pacific Edge (PEB NZ)

52
Analysis
Health CareNew Zealand
Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.
more
bullishPacific Edge
01 Dec 2022 08:01Broker

Pacific Edge (PEB): 1H23 Result – Initial Impressions

Pacific Edge (PEB) reported a 1H23 reported revenue result ahead of our expectations with revenue of NZ$13.6m versus our NZ$9.4m driven by strong...

Logo
277 Views
Share
bullishPacific Edge
24 Oct 2022 06:23Broker

Pacific Edge (PEB): 2Q23 Update – Solid Momentum Continues

Pacific Edge’s (PEB) 2Q23 test volumes highlight ongoing solid momentum with +11% sequential growth versus 1Q23 and +36% year on year

Logo
166 Views
Share
bullishPacific Edge
17 Aug 2022 12:39Broker

Pacific Edge: Balanced On a Knife's Edge

PEB confirmed notification of the inclusion of Cxbladder CPT codes in a draft proposal for a different approach to determine which cancer biomarker...

Logo
210 Views
Share
bullishPacific Edge
27 Jul 2022 08:03Broker

Pacific Edge (PEB): 1Q23 Update

Pacific Edge (PEB)   1Q23 Update Pacific Edge (PEB) has this morning provided a detailed investor update, including 1Q23 lab throughput numbers....

Logo
399 Views
Share
bullishPacific Edge
03 Jun 2022 08:06Broker

Pacific Edge: FY22 Result — Patiently Waiting

Pacific EdgeFY22 Result — Patiently Waiting OUTPERFORM Pacific Edge's (PEB) FY22 result highlighted a continuation of recent trends through 2H22...

Logo
699 Views
Share
x